menopausal symptoms
Recently Published Documents


TOTAL DOCUMENTS

1677
(FIVE YEARS 438)

H-INDEX

66
(FIVE YEARS 7)

2022 ◽  
Vol 8 (4) ◽  
pp. 289-293
Author(s):  
S Ravichandran ◽  
R M Madhumitha Sri ◽  
S Dhandayuthapani ◽  
A Arifa

The main aim of this work was to analyze through a systematic review the ability of Tribulusterrestris to promote the increase of hormonal levels as a mechanism for the relief of menopausal symptoms. The criteria used for the selection were: studies involving menopausal women and use of Tribulusterrestris as a treatment for sexual dysfunction and / or other menopausal symptoms. The survey of literature shows that women who used Tribulusterrestris had drastic improvement in symptoms such as vaginal lubrication, sensation in the genitals during intercourse and other constructive activities. In this study, we have found a significant increase in bioavailable testosterone after the use of the plant extracts which has great potential in the treatment of sexual intercourse and unique symptoms of menopause.


2022 ◽  
pp. 1-13
Author(s):  
Mengfei Ye ◽  
Mengna Shou ◽  
Jian Zhang ◽  
Baiqi Hu ◽  
Chunyan Liu ◽  
...  

Abstract Background T long-term effects of cognitive therapy and behavior therapy (CTBT) for menopausal symptoms are unknown, and whether the effects are different between natural menopause and treatment-induced menopause are currently unclear. Therefore, we sought to conduct an accurate estimate of the efficacy of CTBT for menopausal symptoms. Methods We conducted searches of Cochrane Library, EMBASE, PsycINFO, PubMed, and Web of Science databases for studies from 1 January 1977 to 1 November 2021. Randomized controlled trials (RCTs) comparing intervention groups to control groups for menopausal symptoms were included. Hedge's g was used as the standardized between-group effect size with a random-effects model. Results We included 14 RCTs comprising 1618 patients with a mean sample size of 116. CTBT significantly outperformed control groups in terms of reducing hot flushes [g = 0.39, 95% confidence interval (CI) 0.23–0.55, I2 = 45], night sweats, depression (g = 0.50, 95% CI 0.34–0.66, I2 = 51), anxiety (g = 0.38, 95% CI 0.23–0.54, I2 = 49), fatigue, and quality of life. Egger's test indicated no publication bias. Conclusions CTBT is an effective psychological treatment for menopausal symptoms, with predominantly small to moderate effects. The efficacy is sustained long-term, although it declines somewhat over time. The efficacy was stronger for natural menopause symptoms, such as vasomotor symptoms, than for treatment-induced menopause symptoms. These findings provide support for treatment guidelines recommending CTBT as a treatment option for menopausal symptoms.


Menopause ◽  
2022 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Mankamal Kaur ◽  
Maninder Kaur

2022 ◽  
Vol 05 (01) ◽  
Author(s):  
Masayo Yasuda ◽  
Kayoko Ito ◽  
Kaname Nohno ◽  
Kiyoshi Takamatsu ◽  
Mariko Ogawa ◽  
...  

2021 ◽  
Vol 50 (1) ◽  
pp. 18-22
Author(s):  
A. F. Urmancheeva ◽  
L. M. Bernstein ◽  
М. M. Бурмина ◽  
D. R. Zeldovich ◽  
V. B. Gamayunova ◽  
...  

Radical surgical treatment with and without radiation often induces symptoms of premature menopause in cervical cancer (CC) patients. Few retrospective studies seem to suggest that hormonal replacement therapy (HRT) is not detrimental for patients with CC and can improve life quality in this group of women. To investigate the effect of HRT on menopausal symptoms inpatients with С C history, 85 patients after CC treatment, 22-51 years old, were included into this research. In 59 patients HRT was carried out to overcomepostovariectomic syndrome (POES). Severity of menopausal symptoms, serum estradiol, FSH and lipid profiles were evaluated. The research showed high therapeutic effect as to reducing the frequency of postovariectomic frustration in HRT application. No recurrences of CC were observed in this group of patients. HRT side effects were extremely rare. HRT can effectively cure climacteric symptoms in women with surgical menopause induced by CC treatment.


Molecules ◽  
2021 ◽  
Vol 26 (24) ◽  
pp. 7421
Author(s):  
Maša Kenda ◽  
Nina Kočevar Glavač ◽  
Milan Nagy ◽  
Marija Sollner Dolenc ◽  

Herbal products are often used as an alternative to pharmacological therapy. Menopausal symptoms and gynecological disorders (such as premenstrual syndrome and dysmenorrhea) are the indications where pharmacological therapy may have serious adverse events, hence many women prefer to use herbal products to help with these symptoms. Here, we reviewed plants and derived products, which are commonly used for the abovementioned indications, focusing on clinical data, safely profile and whether or not their use is justified. We noted that limited data are available on the use of some plants for alleviating the symptoms of menopause and gynecological disorders. While black cohosh (Cimicifuga racemose) and red clover (Trifolium pretense) were consistently shown to help reduce menopausal symptoms in clinical studies, currently available data do not fully support the use of fenugreek (Trigonella foenum-graecum), hops (Humulus lupulus), valerian (Valeriana officinalis), and soybean (Glycine max and Glycine soja) for this indication. For premenstrual syndrome and premenstrual dysphoric disorder, chaste tree (Vitex agnus-castus) shows effectiveness, but more clinical studies are needed to confirm such effect upon the use of evening primrose (Oenothera biennis).


2021 ◽  
Vol 2 ◽  
Author(s):  
Robin Andrews ◽  
Gabrielle Hale ◽  
Bev John ◽  
Deborah Lancastle

Evidence suggests that monitoring and appraising symptoms can result in increased engagement in medical help-seeking, improved patient-doctor communication, and reductions in symptom prevalence and severity. To date, no systematic reviews have investigated whether symptom monitoring could be a useful intervention for menopausal women. This review explored whether symptom monitoring could improve menopausal symptoms and facilitate health-related behaviours. Results suggested that symptom monitoring was related to improvements in menopausal symptoms, patient-doctor communication and medical decision-making, heightened health awareness, and stronger engagement in setting treatment goals. Meta-analyses indicated large effects for the prolonged use of symptom diaries on hot flush frequencies. Between April 2019 and April 2021, PsychInfo, EMBASE, MEDLINE, CINAHL, Cochrane, ProQuest, PsychArticles, Scopus, and Web of Science were searched. Eighteen studies met the eligibility criteria and contributed data from 1,718 participants. Included studies quantitatively or qualitatively measured the impact of symptom monitoring on menopausal populations and symptoms. Research was narratively synthesised using thematic methods, 3 studies were examined via meta-analysis. Key themes suggest that symptom monitoring is related to improvements in menopausal symptoms, improved patient-doctor communication and medical decision-making, increased health awareness, and stronger engagement in goal-setting behaviours. Meta-analysis results indicated large effects for the prolonged use of symptom diaries on hot flush frequency: 0.73 [0.57, 0.90]. This review is limited due to the low number of studies eligible for inclusion, many of which lacked methodological quality. These results indicate that symptom monitoring has potential as an effective health intervention for women with menopausal symptoms. This intervention may be beneficial within healthcare settings, in order to improve patient-doctor relations and adherence to treatment regimes. However, findings are preliminary and quality assessments suggest high risk of bias. Thus, further research is needed to support these promising outcomes.Systematic Review Registration Number:https://www.crd.york.ac.uk/prospero/display_record.php?, PROSPERO, identifier: CRD42019146270.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
LiRong Wang ◽  
Rui Zhang ◽  
Ye Yang ◽  
XiaoYan Sun ◽  
BaoLi Zhang ◽  
...  

Abstract Objective To investigate the severity and risk factors of menopausal symptoms in the middle-aged women in Gansu Province of China. Methods In this cross-sectional study, a total of 7319 women (aged 40–55 years) attended the health survey in Gansu Province in China were enrolled. Information on demographics, menopausal status, reproductive history, and history of chronic diseases was collected via a structured questionnaire. Severity of menopausal symptom was evaluated by the Modified Kupperman Menopausal Index. Ordinal logistic regression model was applied to explore its risk factors. Results A total of 7319 participants were included in present study, among them, 3606 (49.27%) had moderate or severe menopausal symptom. Compared with premenopausal women, perimenopausal and postmenopausal women have a higher mKMI score. We observed that older age, higher BMI, non-married status, longer duration of menstruation (≥ 7 days), number of pregnancy (> 3 times), longer duration of breastfeeding (> 12 months), peri- or post-menopausal status, and menopause hormone therapy was positively associated with menopausal symptom score, while higher level of family income, educational and physical activity, and history of gynecological, breast or chronic disease were negatively associated with the score. Conclusions Numerous factors were associated with the severity of menopausal symptom among the Chinese women. Because it was gradually increased with aging, more attention is warranted to manage the menopausal symptom.


Sign in / Sign up

Export Citation Format

Share Document